TEDD Annual Meeting 2019: Cell Sources and Stem Cell Generation for Drug Development.
This year TEDD will hold its Annual Meeting 2019 on October 24, 2019 under the motto: Cell Sources and Stem Cell Generation for Drug Development. The TEDD Annual Meeting brings together experts from diverse fields with a shared interest in advanced 3D models.
Primary and stem cells are becoming relevant sources for the generation of organotypic tissue models used in many biopharmaceutical applications, regenerative medicine, disease modelling and drug discovery. They promise to revolutionize the drug discovery process at all stages, from target identification through to toxicology studies.
While primary cells by nature represent the native tissue most accurately, they usually have limited capacity to divide. Thus, they need to be freshly isolated for each assay, which limits their application. In contrast, the ability of stem cells to generate physiologically relevant cells in an almost limitless supply makes them an attractive alternative to currently used recombinant cell lines or primary cells. Emerging technologies involve the production of organoids from human pluripotent stem cells (hPSCs) and the use of organ-on-a-chip devices. These approaches are showing great promise for developing more reliable, rapid and cost-effective processes when compared with the current use of animal models. Challenges include routinely directing stem cell differentiation to reproducibly and cost-effectively generate pure specific lineages.
During the TEDD Annual Meeting, we will discuss how stem cells have already been used in the drug discovery process and how novel technologies can be applied to attain widespread adoption of stem cell technology by the pharmaceutical and biotech industry. Speakers:
--Dr Marisa Jaconi, University of Geneva, Department of Pathology and Immunology, Switzerland
--Prof. Cornelia Kasper, University of Natural Resources and Life Sciences, Austria
--Prof. Phil Stephens, Cardiff University, UK
--Prof. Kenneth Lee, Chinese University of Hong Kong, HK
--Prof. Zhongze Gu, Southeast University, China
--Dr Wing Chan, STEMCELL Technologies, UK
--Dr Parto Toofan, REPROCELL Europe, UK
TEDD invites sponsors and exhibitors to participate in the TEDD Annual Meeting 2019 actively. The famous two-hour long networking lunch will host between 16-18 invited companies at the Greenhouse, where all participants are present. The call for exhibitors is now open. Spaces are allocated on a first-come-first-served basis. Interested companies can contact exhibition manager Simon Stebler at email@example.com.
More info and the conference program can be found at: https://www.zhaw.ch/icbt/tedd Registration will open in August.
Dr Katarzyna Kopanska +41 589 345 429 firstname.lastname@example.org
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||TEDD--Tissue Engineering For Drug Development and Substance Testing|
|Publication:||ALTEX: Alternatives to Animal Experimentation|
|Date:||Jun 22, 2019|
|Previous Article:||R2N welcomes over 3000 visitors to the stand at the IdeenExpo.|
|Next Article:||TEDD Sino-Swiss Workshop on Tissue Engineering.|